Skip to main content
Top
Published in: Journal of Cancer Education 4/2019

01-08-2019

Focus Groups and In-depth Interviews to Guide the Development of Lung Cancer Screening Informational Materials

Authors: Anushree Sharma, Richard O’Connor, Paula Celestino, Samantha Killion, Laurie Griswold-Krupski, Maansi Bansal-Travers

Published in: Journal of Cancer Education | Issue 4/2019

Login to get access

Abstract

Lung cancer is one of the most lethal cancers in the USA. In 2013, new guidelines issued by the United States Preventive Services Task Force recommended lung cancer screening using low-dose computed tomography among a selected group of high-risk individuals. Specifically, lung cancer screening is recommended for heavy smokers between the ages of 55 to 79, with at least 30 pack-year smoking exposure. Former smokers who meet these guidelines and stopped smoking ≤ 15 years ago are also eligible. There is a need to promote lung cancer screening to increase early diagnosis rates and treatment options, thereby decreasing disease-specific mortality. This study was conducted to refine educational materials used to inform eligible high-risk individuals about the risks and benefits of lung cancer screening. Focus groups (n = 16) and in-depth telephone interviews (n = 5) were conducted among screening-eligible participants recruited from western New York. Main themes that emerged from the discussions included cost of obtaining the exam, eligibility criteria/information about the exam, apprehension regarding results, and an increased desire for discussions with their physician to learn more about the screening. The information gained from this study is vital to understanding concerns held by current and former smokers regarding lung cancer screening, as well as critical to determining which information is most valuable for decreasing barriers and correcting misperceptions about the lung cancer screening exam.
Literature
1.
go back to reference Team, N.L.S.T.R (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011(365):395–409 Team, N.L.S.T.R (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011(365):395–409
2.
go back to reference Moyer VA (2014) Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 160(5):330–338CrossRefPubMed Moyer VA (2014) Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 160(5):330–338CrossRefPubMed
4.
go back to reference Verma V, Beriwal S (2015) Medicare approves coverage for lung cancer screening: the case for symptomatic screening. JAMA Oncol 1(8):1027–1028CrossRefPubMed Verma V, Beriwal S (2015) Medicare approves coverage for lung cancer screening: the case for symptomatic screening. JAMA Oncol 1(8):1027–1028CrossRefPubMed
5.
go back to reference Siu AL, Bibbins-Domingo K, Grossman D (2015) Evidence-based clinical prevention in the era of the Patient Protection and Affordable Care Act: the role of the US Preventive Services Task Force. JAMA 314(19):2021–2022CrossRefPubMed Siu AL, Bibbins-Domingo K, Grossman D (2015) Evidence-based clinical prevention in the era of the Patient Protection and Affordable Care Act: the role of the US Preventive Services Task Force. JAMA 314(19):2021–2022CrossRefPubMed
7.
go back to reference Ersek JL, Eberth JM, McDonnell KK, Strayer SM, Sercy E, Cartmell KB, Friedman DB (2016) Knowledge of, attitudes toward, and use of low-dose computed tomography for lung cancer screening among family physicians. Cancer 122(15):2324–2331CrossRefPubMed Ersek JL, Eberth JM, McDonnell KK, Strayer SM, Sercy E, Cartmell KB, Friedman DB (2016) Knowledge of, attitudes toward, and use of low-dose computed tomography for lung cancer screening among family physicians. Cancer 122(15):2324–2331CrossRefPubMed
8.
go back to reference Delmerico J, Hyland A, Celestino P, Reid M, Cummings KM (2014) Patient willingness and barriers to receiving a CT scan for lung cancer screening. Lung Cancer 84(3):307–309CrossRefPubMedPubMedCentral Delmerico J, Hyland A, Celestino P, Reid M, Cummings KM (2014) Patient willingness and barriers to receiving a CT scan for lung cancer screening. Lung Cancer 84(3):307–309CrossRefPubMedPubMedCentral
9.
go back to reference Selvin E, Brett KM (2003) Breast and cervical cancer screening: sociodemographic predictors among White, Black, and Hispanic women. Am J Public Health 93(4):618–623CrossRefPubMedPubMedCentral Selvin E, Brett KM (2003) Breast and cervical cancer screening: sociodemographic predictors among White, Black, and Hispanic women. Am J Public Health 93(4):618–623CrossRefPubMedPubMedCentral
10.
go back to reference Byrne MM, Weissfeld J, Roberts MS (2008) Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Mak 28(6):917–925CrossRef Byrne MM, Weissfeld J, Roberts MS (2008) Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Mak 28(6):917–925CrossRef
11.
go back to reference Gilbert H, Sutton S, Sutherland G (2005) Who Calls QUIT®? The characteristics of smokers seeking advice via a telephone helpline compared with smokers attending a clinic and those in the general population. Public Health 119(10):933–939CrossRefPubMed Gilbert H, Sutton S, Sutherland G (2005) Who Calls QUIT®? The characteristics of smokers seeking advice via a telephone helpline compared with smokers attending a clinic and those in the general population. Public Health 119(10):933–939CrossRefPubMed
12.
13.
go back to reference Kanodra NM, Pope C, Halbert CH, Silvestri GA, Rice LSJ, Tanner NT (2016) Primary care provider and patient perspectives on lung cancer screening. A qualitative study. Ann Am Thorac Soc 13(11):1977–1982CrossRefPubMed Kanodra NM, Pope C, Halbert CH, Silvestri GA, Rice LSJ, Tanner NT (2016) Primary care provider and patient perspectives on lung cancer screening. A qualitative study. Ann Am Thorac Soc 13(11):1977–1982CrossRefPubMed
Metadata
Title
Focus Groups and In-depth Interviews to Guide the Development of Lung Cancer Screening Informational Materials
Authors
Anushree Sharma
Richard O’Connor
Paula Celestino
Samantha Killion
Laurie Griswold-Krupski
Maansi Bansal-Travers
Publication date
01-08-2019
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 4/2019
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-018-1362-4

Other articles of this Issue 4/2019

Journal of Cancer Education 4/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine